Comparative analysis of the drug-drug interaction between immunosuppressants, safety and efficacy of rifabutin from rifampicin-based Anti-TB treatment in living donor liver transplant recipients with active tuberculosis

BACKGROUND: The Interaction between anti-tuberculous and immunosuppressive drugs which may increase the risk of graft rejections is a major challenge in managing transplant recipients with tuberculosis (TB). Instead of rifampicin (RFM), most guidelines recommended the use of rifabutin (RFB) because...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu-Chen, Salvador, Noruel Gerard, Lin, Chih-Che, Wu, Chao-Chien, Lin, Ting-Lung, Lee, Wei-Feng, Chan, Yi-Chia, Chen, Chao-Long, Co, Jeffrey Samuel, Encarnacion, Domelle Dave
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chang Gung University 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068555/
https://www.ncbi.nlm.nih.gov/pubmed/35300949
http://dx.doi.org/10.1016/j.bj.2020.08.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068555/
https://www.ncbi.nlm.nih.gov/pubmed/35300949
http://dx.doi.org/10.1016/j.bj.2020.08.010

Ejemplares similares